Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
255.00
-6.08 (-2.33%)
At close: Mar 11, 2026, 4:00 PM EDT
253.60
-1.40 (-0.55%)
After-hours: Mar 11, 2026, 7:55 PM EDT

Krystal Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,4547,1974,5113,5032,0411,763
Market Cap Growth
42.89%59.55%28.77%71.63%15.75%49.07%
Enterprise Value
6,5086,3773,9192,9771,6691,332
Last Close Price
255.00246.54156.66124.0679.2269.95
PE Ratio
37.2836.0452.22318.10-14.43-22.35
Forward PE
32.2934.8933.31---
PEG Ratio
0.91-----
PS Ratio
19.1618.5015.5369.09--
PB Ratio
6.105.904.774.503.912.97
P/TBV Ratio
6.266.064.924.423.872.62
P/FCF Ratio
39.4638.1037.85-34.82-13.29-15.17
P/OCF Ratio
37.1135.8336.55-39.45-20.29-36.78
EV/Sales Ratio
16.7216.3913.4958.73--
EV/EBITDA Ratio
39.9437.9954.09-28.71-11.77-20.34
EV/EBIT Ratio
40.3539.5359.61-27.16-11.50-19.51
EV/FCF Ratio
34.4533.7532.89-29.60-10.87-11.46
Debt / Equity Ratio
0.010.010.010.010.010.01
Debt / EBITDA Ratio
0.060.060.10-0.08-0.06-0.12
Debt / FCF Ratio
0.050.050.06-0.08-0.06-0.07
Net Debt / Equity Ratio
-0.67-0.67-0.62-0.67-0.71-0.72
Net Debt / EBITDA Ratio
-4.88-4.88-8.155.052.616.57
Net Debt / FCF Ratio
-4.33-4.33-4.955.212.413.70
Asset Turnover
0.330.330.310.0700
Inventory Turnover
0.690.691.200.89--
Quick Ratio
9.289.286.8917.3513.1417.02
Current Ratio
9.959.957.2817.7613.3017.18
Return on Equity (ROE)
18.91%18.91%10.34%1.68%-25.09%-15.71%
Return on Assets (ROA)
14.59%14.59%6.56%-13.50%-24.51%-14.57%
Return on Invested Capital (ROIC)
45.74%45.74%20.09%-45.71%-92.04%-69.71%
Return on Capital Employed (ROCE)
14.77%14.77%7.56%-16.67%-25.69%-15.24%
Earnings Yield
2.75%2.77%1.91%0.31%-6.93%-4.47%
FCF Yield
2.53%2.62%2.64%-2.87%-7.52%-6.59%
Buyback Yield / Dilution
-0.12%-0.12%-0.60%-5.79%-1.73%-20.17%
Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q